Market Cap: $1.09B
HI
Harrow Health, Inc.
HROW
NASDAQ (NASDAQ Global Market)USD
Market Cap: $1.09B
Harrow (Ticker: HROW) is actively enhancing the accessibility and education surrounding its cyclosporine ophthalmic emulsion, VERKAZIA, aimed specifically at treating vernal keratoconjunctivitis. Afte…
Harrow (Ticker: HROW) has recently made significant advancements in the treatment of vernal keratoconjunctivitis (VKC), a condition that has traditionally been overlooked, particularly in the pediatri…
Harrow Inc. Addresses Mixed Fourth Quarter Results amid Growth Aspirations Harrow Inc. (NASDAQ:HROW) reports its fourth-quarter results, demonstrating a notable 42% increase in total revenue, totaling…
Harrow Health's Impressive Q4 Growth Signals Market Commitment Harrow Health showcases a robust performance in its fourth quarter, cementing its strategic position within the specialty pharmaceutical…
Harrow's Innovative Growth in the Specialty Pharmaceuticals Sector Harrow (NASDAQ:HROW) reveals promising performance in its Q4 earnings report, showcasing a significant revenue growth of 15% year-ove…
Navigating Market Volatility: Harrow's Strategic Focus Amid Economic Uncertainty As U.S. stock futures show a decline, the pharmaceutical sector, including companies like Harrow Health, remains alert…
Earnings Reports: A Crucial Window into Company Operations As various companies prepare to announce their earnings, the focus sharpens on how these reports can illuminate operational efficiencies and…
Harrow Health: Navigating the Landscape of Earnings Reports Harrow Health, a company specializing in ophthalmic pharmaceuticals, finds itself amidst a critical phase as it approaches its earnings repo…
Harrow Expands Portfolio with Strategic Acquisition of Melt Pharmaceuticals Harrow, Inc., a prominent player in ophthalmic disease management, recently announces its acquisition of Melt Pharmaceutical…
Harrow Health: A Bright Spot in Eyecare Innovation Harrow Health emerges as a key player in the eyecare market, drawing attention from analysts who recognize its profitable position within a rapidly e…
Harrow Inc. and Formosa Pharmaceuticals Forge Strategic Alliance in Ophthalmic Care Harrow Inc. (HROW) announces a pivotal licensing agreement with Taiwan-based Formosa Pharmaceuticals, marking a sign…
Strengthening Energy Infrastructure: A Rising Tide for Pipeline Companies In the ever-changing landscape of the energy sector, the importance of pipeline infrastructure becomes increasingly evident. C…
Harrow Health's Steady Position Amid Market Volatility In the current landscape of the pharmaceutical and biotechnology industries, Harrow Health maintains a neutral stance, reflecting a measured appr…
Harrow's Strategic Positioning in the Healthcare Market Harrow Health, a leader in the ophthalmic pharmaceutical sector, maintains a neutral outlook amidst a fluctuating market landscape. The company'…
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer, Strengthening Eyecare Innovation Harrow, a leading North American eyecare pharmaceutical company, recently announces the appointment of Ami…
Harrow Pharmaceuticals Welcomes New Chief Scientific Officer to Propel Eyecare Innovation Harrow Pharmaceuticals, a leading North American eyecare pharmaceutical company, appoints Amir H. Shojaei, Pha…
Harrow’s Strategic Engagement at Upcoming Investor Conferences Harrow, Inc., a leading North American eyecare pharmaceutical company, announces its participation in three significant investor conferen…
Harrow Launches Access and Affordability Program for Ophthalmic Products Harrow, a leading North American eyecare pharmaceutical company, introduces an Access and Affordability Program designed to imp…
Harrow Enhances Patient Access to Eyecare Through New Affordability Initiative Harrow, a leading North American eyecare pharmaceutical company, introduces an innovative Access and Affordability Progra…
Harrow Enhances Patient Access to Eyecare Medications Through Strategic Collaboration Harrow, a leading North American eyecare pharmaceutical company, has launched a groundbreaking digital patient acc…
Harrow's Commitment to Eyecare Innovation Shines in Upcoming Financial Update Harrow, a leading North American eyecare pharmaceutical company, is poised to release its financial results for the third…